VARGATEF EFEV Trademark

Trademark Overview

On Wednesday, May 9, 2012, a trademark application was filed for VARGATEF EFEV with the United States Patent and Trademark Office. The USPTO has given the VARGATEF EFEV trademark a serial number of 79114861. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, May 9, 2022. This trademark is owned by Boehringer Ingelheim International GmbH. The VARGATEF EFEV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
vargatef efev

General Information

Serial Number79114861
Word MarkVARGATEF EFEV
Filing DateWednesday, May 9, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, May 9, 2022
Registration Number4299831
Registration DateTuesday, March 12, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 25, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
Translation of Words in MarkTo the knowledge of applicant, "VARGATEF" nor "EFEV" has any meaning in any language other than as a trademark of applicant in the form of "VARGATEF EFEV".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Wednesday, January 4, 2023UNDELIVERABLE MAIL - NO ACTION TAKEN
Sunday, December 4, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, December 4, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, July 31, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, July 9, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, July 9, 2020INVALIDATION PROCESSED
Thursday, June 18, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 18, 2019CANCELLED SECTION 71
Sunday, July 7, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, June 14, 2013FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 14, 2013FINAL DISPOSITION PROCESSED
Wednesday, June 12, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 12, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, December 25, 2012PUBLISHED FOR OPPOSITION
Sunday, December 23, 2012NOTIFICATION PROCESSED BY IB
Wednesday, December 5, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 5, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 5, 2012NOTICE OF PUBLICATION
Sunday, November 18, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 5, 2012AMENDMENT FROM APPLICANT ENTERED
Tuesday, October 9, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 5, 2012APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, October 20, 2012ASSIGNED TO LIE
Tuesday, October 9, 2012PAPER RECEIVED
Sunday, September 30, 2012REFUSAL PROCESSED BY IB
Tuesday, September 18, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 7, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 6, 2012REFUSAL PROCESSED BY MPU
Thursday, September 6, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 5, 2012NON-FINAL ACTION WRITTEN
Friday, August 31, 2012NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Friday, August 31, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 30, 2012NON-FINAL ACTION WRITTEN
Thursday, August 30, 2012ASSIGNED TO EXAMINER
Tuesday, July 31, 2012APPLICATION FILING RECEIPT MAILED
Friday, July 27, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 26, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 26, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

efev vargatef system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary